Patent · US Active

Heteroaryl butanoic acid derivatives

US9981926B2 · kind B2 · utility

0Cited by

10References

22Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Birgit Bollbuck · Munich, DE
Christian Markert · Herbrechtingen, DE
Wolfgang Miltz · Basel, CH
Till Roehn · Zürich, CH

Key dates

Filing date	Dec 18, 2014
Grant date	May 29, 2018
Priority date	—
Expiry date	Dec 18, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various diseases and disorders, and processes for preparing the said novel compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.